+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Structural Heart Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • ID: 4749578
  • Report
  • January 2019
  • Region: Global
  • Acute Market Reports
1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • C. R. Bard, Inc.
  • Comed B.V.
  • CryoLife, Inc.
  • LivaNova PLC
  • Medtronic PLC
  • MORE
The global structural heart devices market was valued at US$ 7.5 Bn in 2017 and expected to reach US$ 18.9 Bn by 2026, expanding at a CAGR of 10.7% from 2018 to 2026.

Market Insights

Structural heart diseases are non-coronary abnormalities comprise conditions which are either congenital or due to certain abnormalities developed in heart valves, and vessels due to age or underlying conditions. Common conditions respective to heart structure include paravalvular leak, ventricular septal defect, arterial venous fistulae, patent foramen oval, and so on. Significantly large prevalence of cardiovascular abnormalities. In the U.S. alone approximately 60 million individuals presenting 20% of the total population suffers from structural heart defects. This represents a significant opportunity for the use of structural heart devices. These conditions present a wide category of treatment including both repair and replacement procedures, for both acquired and congenital diseases.

Favorable reimbursements for the novel minimally invasive procedures have made procedures such as TAVR highly popular and affordable to the patients. As the global population is aging, the medical expenditure in several countries is being covered by the government and private insurers. This eases the per capita healthcare burden, therefore urging more and more patients to opt for such treatments. Furthermore, increasing awareness about the novel procedures and increasing availability of long-lasting implants drive the global market growth.

The major market players are also increasing their investments in research and development activities to enhance the effectiveness of these devices. It is expected that by 2020 some prominent and advanced pipeline products shall be commercialized. Boston Scientific Corporation, Abbott Laboratories, Medtronic, Edwards Lifesciences Corporation are some of the leading companies in this space.

Based on the type of devices, the global structural heart devices market is segmented into heart valve devices, repair devices, and accessories. Among these, the demand for heart valve devices is set to be the highest during the forecast period. Similarly, the replacement procedures segment in terms of procedure types is estimated to undergo the fastest market growth. Consistent growth in the geriatric population, rapid adoption of transcatheter aortic valve replacement therapies, and an affordable process of replacement procedures contribute to the rapid growth of this segment. Additionally, North America and Asia Pacific markets are the most prominent regions to watch during the forecast period in terms of revenue and market growth respectively. Asia Pacific region will progress at the fastest CAGR during the forecast period. Considering the competitive landscape, the global structural heart valve devices have rapidly changing dynamics. The new market entrants with promising pipeline devices are often being acquired by incumbent players with rich financial pool. The existing players are also strengthening their geographical foothold through mergers, distribution agreements, and other growth strategies. The major players operating in this market are Abbott Laboratories, Edwards Lifesciences Corporation, Medtronic, Boston Scientific Corporation and others.

Key Market Movements:
  • The growing incidence of congenital heart defects, and high prevalence of age-related structural conditions
  • Growing awareness and reducing procedure costs in the Asia Pacific
  • Intensifying market entry of major market players from developed countries to emerging Asia Pacific region
  • Growing demand for minimally invasive procedures, therefore, paving way for transcatheter procedures
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • C. R. Bard, Inc.
  • Comed B.V.
  • CryoLife, Inc.
  • LivaNova PLC
  • Medtronic PLC
  • MORE
Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Structural Heart Devices Market Portraiture
2.2. Global Structural Heart Devices Market, by Type, 2017 (US$ Mn)
2.3. Global Structural Heart Devices Market, by Procedure, 2017 (US$ Mn)
2.4. Global Structural Heart Devices Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Structural Heart Devices Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Structural Heart Devices Market, by Key Players, 2017

Chapter 4. Global Structural Heart Devices Market, by Type, 2016 - 2026 (US$ Mn)
4.1. Overview
4.2. Heart Valve Devices
4.2.1. Surgical Heart Valves
4.2.2. Transcatheter Heart Valves
4.3. Repair Devices
4.3.1. Occluders and Delivery Systems
4.3.2. Annuloplasty Rings
4.3.3. Others
4.4. Accessories

Chapter 5. Global Structural Heart Devices Market, by Procedure, 2016 - 2026 (US$ Mn)
5.1. Overview
5.2. Repair Procedures
5.2.1. Valvuloplasty
5.2.2. Transcatheter Mitral Valve Repair (TMVR)
5.2.3. Annuloplasty
5.2.4. Others
5.3. Replacement Procedures
5.3.1. Tissue Heart Valves
5.3.2. Mechanical Heart Valves
5.3.3. Transcatheter Aortic Valve Replacement (TAVR)

Chapter 6. Global Structural Heart Devices Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. North America Structural Heart Devices Market, 2016 - 2026 (US$ Mn)
6.2.1. North America Structural Heart Devices Market, by Type, 2016 - 2026 (US$ Mn)
6.2.2. North America Structural Heart Devices Market, by Procedure, 2016 - 2026 (US$ Mn)
6.2.3. North America Structural Heart Devices Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Structural Heart Devices Market, 2016 – 2026 (US$ Mn)
6.3.1. Europe Structural Heart Devices Market, by Type, 2016 - 2026 (US$ Mn)
6.3.2. Europe Structural Heart Devices Market, by Procedure, 2016 - 2026 (US$ Mn)
6.3.3. Europe Structural Heart Devices Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Structural Heart Devices Market, 2016 – 2026 (US$ Mn)
6.4.1. Asia Pacific Structural Heart Devices Market, by Type, 2016 - 2026 (US$ Mn)
6.4.2. Asia Pacific Structural Heart Devices Market, by Procedure, 2016 - 2026 (US$ Mn)
6.4.3. Asia Pacific Structural Heart Devices Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America Structural Heart Devices Market, 2016 – 2026 (US$ Mn)
6.5.1. Latin America Structural Heart Devices Market, by Type, 2016 - 2026 (US$ Mn)
6.5.2. Latin America Structural Heart Devices Market, by Procedure, 2016 - 2026 (US$ Mn)
6.5.3. Latin America Structural Heart Devices Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa Structural Heart Devices Market, 2016 – 2026 (US$ Mn)
6.6.1. Middle East & Africa Structural Heart Devices Market, by Type, 2016 - 2026 (US$ Mn)
6.6.2. Middle East & Africa Structural Heart Devices Market, by Procedure, 2016 - 2026 (US$ Mn)
6.6.3. Middle East & Africa Structural Heart Devices Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of Middle East & Africa

Chapter 7. Company Profiles
7.1. Abbott Laboratories
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Boston Scientific Corporation
7.3. Edwards Lifesciences Corporation
7.4. Medtronic PLC
7.5. LivaNova PLC
7.6. C. R. Bard, Inc.
7.7. CryoLife, Inc.
7.8. Integer Holdings Corporation
7.9. Comed B.V.
7.10. JenaValve Technology, Inc.

List of Figures
FIG 1. Structural Heart Devices Market: Research Methodology
FIG 2. Market Size Estimation – Top Down & Bottom up Approach
FIG 3. Structural Heart Devices: Market Segmentation
FIG 4. Global Structural Heart Devices Market, by Type, 2017 (US$ Mn)
FIG 5. Global Structural Heart Devices Market, by Procedure, 2017 (US$ Mn)
FIG 6. Global Structural Heart Devices Market, by Geography, 2017 (US$ Mn)
FIG 7. Attractive Investment Proposition, by Geography, 2017
FIG 8. Competitive Analysis: Global Structural Heart Devices Market, by Key Players, 2017
FIG 9. Global Surgical Heart Valves Market, 2016 - 2026 (US$ Mn)
FIG 10. Global Transcatheter Heart Valves Market, 2016 - 2026 (US$ Mn)
FIG 11. Global Occluders and Delivery Systems Market, 2016 - 2026 (US$ Mn)
FIG 12. Global Annuloplasty Rings Market, 2016 - 2026 (US$ Mn)
FIG 13. Global Other Repair Devices Market, 2016 - 2026 (US$ Mn)
FIG 14. Global Structural Heart Accessories Market, 2016 - 2026 (US$ Mn)
FIG 15. Global Structural Heart Devices Market for Valvuloplasty, 2016 - 2026 (US$ Mn)
FIG 16. Global Structural Heart Devices Market for Transcatheter Mitral Valve Repair (TMVR), 2016 - 2026 (US$ Mn)
FIG 17. Global Structural Heart Devices Market for Annuloplasty, 2016 - 2026 (US$ Mn)
FIG 18. Global Structural Heart Devices Market for Other Repair Procedures, 2016 - 2026 (US$ Mn)
FIG 19. Global Structural Heart Devices Market for Tissue Heart Valves, 2016 - 2026 (US$ Mn)
FIG 20. Global Structural Heart Devices Market for Mechanical Heart Valves, 2016 - 2026 (US$ Mn)
FIG 21. Global Structural Heart Devices Market for Transcatheter Aortic Valve Replacement (TAVR), 2016 - 2026 (US$ Mn)
FIG 22. U.S. Structural Heart Devices Market, 2016 - 2026 (US$ Mn)
FIG 23. Canada Structural Heart Devices Market, 2016 - 2026 (US$ Mn)
FIG 24. U.K. Structural Heart Devices Market, 2016 - 2026 (US$ Mn)
FIG 25. Germany Structural Heart Devices Market, 2016 - 2026 (US$ Mn)
FIG 26. Rest of Europe Structural Heart Devices Market, 2016 - 2026 (US$ Mn)
FIG 27. China Structural Heart Devices Market, 2016 - 2026 (US$ Mn)
FIG 28. Japan Structural Heart Devices Market, 2016 - 2026 (US$ Mn)
FIG 29. India Structural Heart Devices Market, 2016 - 2026 (US$ Mn)
FIG 30. Rest of Asia Pacific Structural Heart Devices Market, 2016 - 2026 (US$ Mn)
FIG 31. Brazil Structural Heart Devices Market, 2016 - 2026 (US$ Mn)
FIG 32. Mexico Structural Heart Devices Market, 2016 - 2026 (US$ Mn)
FIG 33. Rest of Latin America Structural Heart Devices Market, 2016 - 2026 (US$ Mn)
FIG 34. GCC Structural Heart Devices Market, 2016 - 2026 (US$ Mn)
FIG 35. Rest of Middle East and Africa Structural Heart Devices Market, 2016 - 2026 (US$ Mn)

List of Tables
TABLE 1 Global Structural Heart Devices Market Portraiture
TABLE 2 Global Structural Heart Devices Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Heart Valve Devices Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global Structural Heart Repair Devices Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 5 Global Structural Heart Devices Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 6 Global Structural Heart Devices Market, by Repair Procedure, 2016 – 2026 (US$ Mn)
TABLE 7 Global Structural Heart Devices Market, by Replacement Procedure, 2016 – 2026 (US$ Mn)
TABLE 8 Global Structural Heart Devices Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 9 North America Structural Heart Devices Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 10 North America Structural Heart Devices Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 11 North America Structural Heart Devices Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 12 Europe Structural Heart Devices Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 13 Europe Structural Heart Devices Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 14 Europe Structural Heart Devices Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 15 Asia Pacific Structural Heart Devices Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 16 Asia Pacific Structural Heart Devices Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 17 Asia Pacific Structural Heart Devices Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 18 Latin America Structural Heart Devices Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 19 Latin America Structural Heart Devices Market, by Procedure, 2016 – 2026 (US$ Mn
TABLE 20 Latin America Structural Heart Devices Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 21 Middle East and Africa Structural Heart Devices Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 22 Middle East and Africa Structural Heart Devices Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 23 Middle East and Africa Structural Heart Devices Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 24 Abbott Laboratories: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Boston Scientific Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Edwards Lifesciences Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Medtronic PLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 LivaNova PLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 C. R. Bard, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 CryoLife, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31 Integer Holdings Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32 Comed B.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33 JenaValve Technology, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Medtronic PLC
  • LivaNova PLC
  • C. R. Bard, Inc.
  • CryoLife, Inc.
  • Integer Holdings Corporation
  • Comed B.V.
  • JenaValve Technology, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll